CTMX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CTMX Shares Outstanding History and CTMX YTD Return |
CTMX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CTMX Shares Outstanding History and CTMX YTD Return |
CTMX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-11.21% CAGR Mouse over chart for data details
|
CTMX Stock Price Chart |
About CytomX Therapeutics Inc |
CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company. Co. is developing an antibody-based therapeutics created using its Probody® therapeutic technology platform. Co.'s products include: Praluzatamab ravtansine, which is an activated antibody-drug conjugates directed against CD166, a tumor target previously considered undruggable due to its high expression on normal tissues; CX-2029, which opens a therapeutic window for targeting CD71; Pacmilimab, which is a Probody therapeutic against PD-L1, a clinically and commercially validated cancer target; and BMS-986249 and BMS-986288, which is the Probody versions of ipilimumab. We show 36 historical shares outstanding datapoints in our CTMX shares outstanding history coverage, used to compute CTMX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CTMX market cap history over the course of time is important for investors interested in comparing CTMX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CTMX versus a peer is one thing; comparing CTMX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CTMX can fluctuate over the course of history. With this page we aim to empower investors researching CTMX by allowing them to research the CTMX market cap history. |
CTMX Current Stock Quote |
Free CTMX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
CTMX Share Performance |
Market Cap Peers |
CytomX Therapeutics (CTMX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CTRV Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.